NORTH AMERICA DRUG DISCOVERY MARKET 2019-2028

Lifesciences | Diagnostic & Biotechnology

NORTH AMERICA DRUG DISCOVERY MARKET 2019-2028

Market by Drug Type, Technology, Service, End-User, and Country | Forecast 2019-2028

Request Free Sample

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

According to research by Triton, North America’s drug discovery market is expected to grow significantly in terms of revenue at a CAGR of 6.57% for the forecasting years 2019-2028.


Report scope can be customized per your requirements. Request For Customization

Countries that have been covered in the drug discovery market in North America are:

•           The United States

•           Canada

The American Cancer Society (ACS) estimates that, in 2020, an estimated 1.8 million people will be diagnosed with cancer in the United States, with around 606,520 cancer deaths. This has led to increased investments in lead optimization to enhance therapeutic value, and, in turn, provide patients with efficient & targeted therapies. According to US FDA’s data, the Center for Drug Evaluation and Research (CDER) had approved 40 novel drugs as of September 2020. These were approved as new molecular entities (NMEs) under New Drug Applications (NDAs) or as new therapeutic biologics under Biologics License Applications (BLAs). Overall, 31,468 patients took part in these trials. This shows that the US is focusing on R&D activities to meet the rising demand from its citizens for better and effective drugs. This is expected to augment the growth of the nation’s drug discovery market.

Further, the interest in high throughput screening (HTS) technologies in the United States has increased drastically in academic research in recent years. Also, a comprehensive database of academic screening centers is available; these centers are hosted by the Society for Biomolecular Sciences. This not only provides HTS resources to the academia, but also helps identify both probes and leads for drug discovery. Also, these centers promote open-source data sharing of small molecule screening data. Moreover, the rising prevalence of chronic diseases has also added to the demand for potential drugs in the US. This rising demand is expected to bolster the market for drug discovery in the future.

Antares Pharma Inc is a specialty pharmaceutical company. It focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies. The company is engaged in developing, manufacturing, and commercializing therapeutic products using its drug delivery systems. Antares is headquartered in New Jersey, the United States.

Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT
ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028
Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT

Table of Content

1.    NORTH AMERICA DRUG DISCOVERY MARKET - SUMMARY

2.    INDUSTRY OUTLOOK

2.1. MARKET DEFINITION

2.2. PORTER'S FIVE FORCES MODEL

2.2.1.   THREATS OF NEW ENTRANTS

2.2.2.   THREAT OF SUBSTITUTE PRODUCTS

2.2.3.   BARGAINING POWER OF BUYERS

2.2.4.   BARGAINING POWER OF SUPPLIERS

2.2.5.   COMPETITIVE RIVALRY

2.3. COVID-19 AND ITS IMPACT ON DRUG DISCOVERY MARKET

2.4. PESTLE OUTLOOK

2.5. REGULATORY FRAMEWORK

2.6. VALUE CHAIN OUTLOOK

2.7. MARKET ATTRACTIVENESS INDEX

2.8. KEY INSIGHT

2.9. MARKET DRIVERS

2.9.1.   GROWING AGED POPULATION

2.9.2.   TECHNOLOGICAL ADVANCEMENTS

2.9.3.   RISE IN HEALTHCARE EXPENDITURE

2.9.4.   SURGE IN LIFESTYLE-ORIENTED DISEASES

2.10.  MARKET RESTRAINTS

2.10.1.   DELAY IN PRODUCT LAUNCHES

2.10.2.  RESTRICTED GROWTH RATE DUE TO GENERIC DRUGS

2.11.  MARKET OPPORTUNITIES

2.11.1.    SIGNIFICANT INVESTMENT BY HEALTHCARE INDUSTRIES IN IMPROVING BIG DATA ANALYTICAL CAPABILITIES

2.11.2.   RISING DEMAND FOR SPECIALTY MEDICINES

2.12.  MARKET CHALLENGES

2.12.1.  STRINGENT GOVERNMENT REGULATIONS

3.    DRUG DISCOVERY MARKET OUTLOOK - BY DRUG TYPE

3.1. SMALL MOLECULE DRUG

3.2. BIOLOGIC DRUG

4.    DRUG DISCOVERY MARKET OUTLOOK - BY TECHNOLOGY

4.1. HIGH THROUGHPUT SCREENING

4.2. BIOCHIPS

4.3. BIOINFORMATICS

4.4. PHARMACOGENOMICS AND PHARMACOGENETICS

4.5. COMBINATORIAL CHEMISTRY

4.6. NANOTECHNOLOGY

4.7. SPECTROSCOPY

4.8. METABOLOMICS

4.9. OTHER TECHNOLOGIES

5.    DRUG DISCOVERY MARKET OUTLOOK - BY SERVICE

5.1. DRUG METABOLISM AND PHARMACOKINETICS (DMPK) SERVICES

5.2. CHEMICAL SERVICES

5.3. BIOLOGICAL SERVICES

5.4. OTHER PHARMACEUTICAL SERVICES

6.    DRUG DISCOVERY MARKET OUTLOOK - BY END-USER

6.1. RESEARCH INSTITUTES

6.2. PHARMACEUTICAL COMPANIES

6.3. CONTRACT RESEARCH ORGANIZATIONS (CROS)

6.4. OTHER END-USERS

7.    DRUG DISCOVER MARKET – NORTH AMERICA

7.1. COUNTRY ANALYSIS

7.1.1.   UNITED STATES

7.1.2.   CANADA

8.    COMPANY PROFILES

8.1. 3M COMPANY

8.2. ABBOTT LABORATORIES INC

8.3. AGILENT TECHNOLOGIES INC

8.4. ANTARES PHARMA INC

8.5. ASTRAZENECA PLC

8.6. BAYER AG

8.7. BECTON DICKINSON & COMPANY (BD)

8.8. BOEHRINGER INGELHEIM

8.9. ELI LILY AND COMPANY

8.10.   F HOFFMANN-LA ROCHE LTD

8.11.   GLAXOSMITHKLINE LLC

8.12.   JOHNSON & JOHNSON

8.13.    MERCK & CO INC

8.14.     NOVARTIS

8.15.    PFIZER INC

8.16.   SANOFI

9.    RESEARCH METHODOLOGY & SCOPE

9.1. RESEARCH SCOPE & DELIVERABLES

9.1.1.   OBJECTIVES OF STUDY

9.1.2.   SCOPE OF STUDY

9.2. SOURCES OF DATA

9.2.1.   PRIMARY DATA SOURCES

9.2.2.   SECONDARY DATA SOURCES

9.3. RESEARCH METHODOLOGY

9.3.1.   EVALUATION OF PROPOSED MARKET

9.3.2.   IDENTIFICATION OF DATA SOURCES

9.3.3.   ASSESSMENT OF MARKET DETERMINANTS

9.3.4.   DATA COLLECTION

9.3.5.   DATA VALIDATION & ANALYSIS

List of table

TABLE 1        NORTH AMERICA DRUG DISCOVERY MARKET, BY COUNTRY, 2019-2028 ($ MILLION)

TABLE 2        NORTH AMERICA DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019-2028 ($ MILLION)

TABLE 3        NORTH AMERICA DRUG DISCOVERY MARKET, BY DRUG TYPE, 2019-2028 ($ MILLION)

TABLE 4        NORTH AMERICA DRUG DISCOVERY MARKET, BY SERVICE, 2019-2028 ($ MILLION)

TABLE 5        NORTH AMERICA DRUG DISCOVERY MARKET, BY END-USER, 2019-2028 ($ MILLION)

TABLE 6        NORTH AMERICA DRUG DISCOVERY MARKET, BY COUNTRY, 2019-2028 ($ MILLION)                   

List of Figures

FIGURE 1      NORTH AMERICA DRUG DISCOVERY MARKET, BY REGION, 2019-2028 ($ MILLION)

FIGURE 2      NORTH AMERICA DRUG DISCOVERY MARKET, BY SMALL MOLECULE DRUG, 2019-2028 ($ MILLION)

FIGURE 3      NORTH AMERICA DRUG DISCOVERY MARKET, BY BIOLOGIC DRUG, 2019-2028 ($ MILLION)

FIGURE 4      NORTH AMERICA DRUG DISCOVERY MARKET, BY HIGH THROUGHPUT SCREENING, 2019-2028 ($ MILLION)

FIGURE 5      NORTH AMERICA DRUG DISCOVERY MARKET, BY BIOCHIPS, 2019-2028 ($ MILLION)

FIGURE 6      NORTH AMERICA DRUG DISCOVERY MARKET, BY BIOINFORMATICS, 2019-2028 ($ MILLION)

FIGURE 7      NORTH AMERICA DRUG DISCOVERY MARKET, BY PHARMACOGENOMICS AND PHARMACOGENETICS, 2019-2028 ($ MILLION)

FIGURE 8      NORTH AMERICA DRUG DISCOVERY MARKET, BY COMBINATORIAL CHEMISTRY, 2019-2028 ($ MILLION)

FIGURE 9      NORTH AMERICA DRUG DISCOVERY MARKET, BY NANOTECHNOLOGY, 2019-2028 ($ MILLION)

FIGURE 10   NORTH AMERICA DRUG DISCOVERY MARKET, BY SPECTROSCOPY, 2019-2028 ($ MILLION)

FIGURE 11   NORTH AMERICA DRUG DISCOVERY MARKET, BY METABOLOMICS, 2019-2028 ($ MILLION)

FIGURE 12   NORTH AMERICA DRUG DISCOVERY MARKET, BY OTHER TECHNOLOGIES, 2019-2028 ($ MILLION)

FIGURE 13   NORTH AMERICA DRUG DISCOVERY MARKET, BY DRUG METABOLISM AND PHARMACOKINETICS (DMPK) SERVICES, 2019-2028 ($ MILLION)

FIGURE 14   NORTH AMERICA DRUG DISCOVERY MARKET, BY CHEMICAL SERVICES, 2019-2028 ($ MILLION)

FIGURE 15   NORTH AMERICA DRUG DISCOVERY MARKET, BY BIOLOGICAL SERVICES, 2019-2028 ($ MILLION)

FIGURE 16   NORTH AMERICA DRUG DISCOVERY MARKET, BY OTHER PHARMACEUTICAL SERVICES, 2019-2028 ($ MILLION)

FIGURE 17   NORTH AMERICA DRUG DISCOVERY MARKET, BY RESEARCH INSTITUTES, 2019-2028 ($ MILLION)

FIGURE 18   NORTH AMERICA DRUG DISCOVERY MARKET, BY PHARMACEUTICAL COMPANIES, 2019-2028 ($ MILLION)

FIGURE 19   NORTH AMERICA DRUG DISCOVERY MARKET, BY CONTRACT RESEARCH ORGANIZATIONS (CROS), 2019-2028 ($ MILLION)

FIGURE 20   NORTH AMERICA DRUG DISCOVERY MARKET, BY OTHER END-USERS, 2019-2028 ($ MILLION)

FIGURE 21   UNITED STATES DRUG DISCOVERY MARKET 2019-2028 ($ MILLION)

FIGURE 22   CANADA DRUG DISCOVERY MARKET 2019-2028 ($ MILLION) 

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$1,500.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$2,200.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

SUBMIT REQUEST
Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

;